{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:47:44Z","timestamp":1720115264981},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deanship of Scientific Research at the King Saud University","award":["RGP-120"],"award-info":[{"award-number":["RGP-120"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.intimp.2018.10.027","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T07:30:55Z","timestamp":1540539055000},"page":"360-365","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism"],"prefix":"10.1016","volume":"65","author":[{"given":"Sheikh F.","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushtaq A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila Y.","family":"AL-Ayadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moureq R.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali R.","family":"Alhoshani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled A.","family":"Al-Hosaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.10.027_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2015"},{"key":"10.1016\/j.intimp.2018.10.027_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10803-004-1038-2","article-title":"Specific genetic disorders and autism: clinical contribution towards their identification","volume":"35","author":"Cohen","year":"2005","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.intimp.2018.10.027_bb0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/npp.2016.158","article-title":"The role of the immune system in autism spectrum disorder","volume":"42","author":"Meltzer","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2018.10.027_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0198-8859(02)00374-9","article-title":"The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder","volume":"63","author":"Torres","year":"2002","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2018.10.027_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/GIM.0b013e31818fd762","article-title":"The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly","volume":"11","author":"Varga","year":"2009","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.intimp.2018.10.027_bb0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.intimp.2018.10.027_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","article-title":"The role of immune dysfunction in the pathophysiology of autism","volume":"26","author":"Onore","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.027_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2018.10.027_bb0045","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pnpbp.2017.08.002","article-title":"Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism","volume":"79","author":"Ahmad","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2018.10.027_bb0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pnpbp.2017.10.001","article-title":"Upregulation of peripheral CXC and CC chemokine receptor expression on CD4+ T cells is associated with immune dysregulation in children with autism","volume":"81","author":"Ahmad","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2018.10.027_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2016.12.019","article-title":"Imbalance between the anti- and pro-inflammatory milieu in blood leukocytes of autistic children","volume":"82","author":"Ahmad","year":"2017","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2018.10.027_bb0060","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","article-title":"Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0065","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.intimp.2018.10.027_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pediatrneurol.2006.06.006","article-title":"HLA-DR4 in families with autism","volume":"35","author":"Lee","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"4\u20135","key":"10.1016\/j.intimp.2018.10.027_bb0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humimm.2006.01.001","article-title":"The association and linkage of the HLA-A2 class I allele with autism","volume":"67","author":"Torres","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/088307389901400608","article-title":"Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism","volume":"14","author":"Comi","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0085","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.humimm.2004.02.026","article-title":"Analysis of HLA genes in families with autoimmune diabetes and thyroiditis","volume":"65","author":"Levin","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnsyn.2010.00136","article-title":"Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders","volume":"2","author":"Garay","year":"2010","journal-title":"Front Synaptic Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2018.10.027_bb0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2018.10.027_bb0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jneuroim.2010.10.025","article-title":"Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders","volume":"232","author":"Ashwood","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pnpbp.2018.04.011","article-title":"Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children","volume":"85","author":"Ahmad","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7612","key":"10.1016\/j.intimp.2018.10.027_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature18626","article-title":"Unexpected role of interferon-\u03b3 in regulating neuronal connectivity and social behaviour","volume":"535","author":"Filiano","year":"2016","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.intimp.2018.10.027_bb0115","doi-asserted-by":"crossref","first-page":"12776","DOI":"10.1073\/pnas.1202556109","article-title":"Modeling an autism risk factor in mice leads to permanent immune dysregulation","volume":"109","author":"Hsiao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.10.027_bb0120","series-title":"The Childhood Autism Rating Scale (CARS) for Diagnostic Screening and Classification in Autism","author":"Schopler","year":"1986"},{"issue":"241","key":"10.1016\/j.intimp.2018.10.027_bb0125","doi-asserted-by":"crossref","first-page":"241ra80","DOI":"10.1126\/scitranslmed.3008706","article-title":"IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells","volume":"6","author":"Noster","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2018.10.027_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.bjp.0706987","article-title":"Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-kappaB","volume":"150","author":"Chen","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0135","first-page":"463","article-title":"Autoimmunity in autism","volume":"10","author":"Enstrom","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.intimp.2018.10.027_bb0140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s10875-004-6241-6","article-title":"Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10","volume":"24","author":"Ashwood","year":"2004","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2018.10.027_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","article-title":"Differential monocyte responses to TLR ligands in children with autism spectrum disorders","volume":"24","author":"Enstrom","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2018.10.027_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2009.09.001","article-title":"Immune proteins in brain development and synaptic plasticity","volume":"64","author":"Boulanger","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2018.10.027_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","article-title":"Cytokines and CNS development","volume":"64","author":"Deverman","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2018.10.027_bb0160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","article-title":"Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders","volume":"155","author":"Hsiao","year":"2013","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2018.10.027_bb0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humimm.2006.02.033","article-title":"A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder","volume":"67","author":"Guerini","year":"2006","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2018.10.027_bb0170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0753-3322(03)00099-4","article-title":"Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children","volume":"57","author":"Ferrante","year":"2003","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.intimp.2018.10.027_bb0175","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpediatrics.2009.74","article-title":"HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy","volume":"163","author":"Johnson","year":"2009","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"8","key":"10.1016\/j.intimp.2018.10.027_bb0180","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00125-003-1157-x","article-title":"The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens","volume":"46","author":"Sadeharju","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2018.10.027_bb0185","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.10.027_bb0190","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.4049\/jimmunol.176.12.7676","article-title":"Segal B. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis","volume":"176","author":"Bagaeva","year":"2006","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2018.10.027_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2008.04.010","article-title":"Enhanced expression of the CXCl12\/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain","volume":"198","author":"Sch\u00f6nemeier","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2018.10.027_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2040-2392-2-13","article-title":"Increased midgestational IFN-\u03b3, IL-4 and IL-5 in women bearing a child with autism: a case-control study","volume":"2","author":"Goines","year":"2011","journal-title":"Mol. Autism"},{"issue":"7152","key":"10.1016\/j.intimp.2018.10.027_bb0210","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2018.10.027_bb0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2018.10.027_bb0220","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajpath.2010.10.043","article-title":"IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain","volume":"178","author":"Tzartos","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2018.10.027_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.gene.2016.10.019","article-title":"FOXP3 gene variations and susceptibility to autism: a case-control study","volume":"596","author":"Safari","year":"2017","journal-title":"Gene"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691830540X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691830540X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:21:42Z","timestamp":1543263702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691830540X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":45,"alternative-id":["S156757691830540X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.10.027","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}